(PharmaNewsWire.Com, April 20, 2017 ) Asia-Pacific Influenza research report, published by Market Data Forecast delineates that the market is growing with a CAGR of 10.70 % to reach USD 2.18 billion by 2021, from USD 1.31 billion in 2016, which amounts to a cumulative growth of USD 0.89 billion.
Influenza or flu is a type of transmittable respiratory disease that affect throat, nose, and lungs. Influenza viruses are of three types-Type A (H2N2, H1N1, and H5N1), Type C and Type B. It can be either pandemic, seasonal, or zoonotic. Asia-Pacific Influenza Market can be fatal if goes unnoticed and is regarded as a major reason of mortality, globally. Some of the symptoms of influenza are sore throat, cough, fever, stuffy or runny nose, fatigue, body ache and headache.
The report also presents detailed analysis of multitude of factors affecting the Influenza Market bearing either positive or negative outcomes. Some of those factors are rising public awareness boost in healthcare expenditure cost-effectiveness of immunization introduction of new medicines Increasing government initiatives for vaccination against influenza viruses. Additionally, a large section of population, in Asia-Pacific are not immunized against influenza virus, thereby fueling the demand for the product in the region. antigenic shift of influenza virus lack of cold storage facility side-effects of product (soreness, allergic reactions, swelling, and redness) Remote areas with limited accessibility. For granular level understanding the Influenza Market is segmented based on type and application, each being provided with Market Size Estimations and Y-o-Y Forecasts. Based on Product Type (Vaccines and Drugs), based on Consumer (Children and Adults), and by Region
With India and China being the major economies which have unexplored customer base covered in the study the report also focuses on other regions like Japan, Australia, South Korea and Rest of Asia-Pacific.
Some of the key players that operate in the Asia-Pacific Influenza market include Merck & Co. (U.S.), AstraZeneca (United Kingdom), Sanofi-Pasteur (U.S.), GlaxoSmithKline (U.K.), Novartis (Switzerland), Pfizer Inc. (U.S.), Abbott Laboratories (U.S.), Mitsubishi Tanabe Pharma Corporation (Japan), CSL Limited (Australia), F. Hoffmann-La Roche (Switzerland), The Asia- Pacific Influenza market report offers wide-range of scope: Regional and country-level analysis that provides an individual perspective of Asia-Pacific region and the aforementioned countries Know more about key areas of industry growth via detailedSegment-level analysis on basis of Product type and Consumer long with market size forecasts and y-o-y estimations Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics Strategic Analyses containingPESTLE and Porters Five Forces Analyseswhich are obtained by studying the macro & micro environmental factors that affect the market demographics Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies Market Outlook - Investment opportunitiesdevised by stand in experts to provide both individuals and organizations a strong financial foothold in the market
For more reports related to the Pharmaceuticals Market:
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
